Document Classification

Section Type: RESULTS

Text: Multivariate survival analyses adjusting for age, tumor size, nodal status, menopausal status, surgery type, histological grade, hormone receptor status, human epidermal growth factor receptor 2 (HER2) status, chemotherapy regimen, and under-treatment showed that obese patients (BMI 30. 0 to 34. 9) had similar prognoses to that of patients with a BMI < 25 (reference group) in terms of recurrence (Hazard Ratio [HR] = 1. 08, 95 % Confidence Interval [CI] = 0. 90 to 1. 30), BCM (HR = 1. 02, 0. 81 to 1. 29), and OM (HR = 0. 97, 0. 78 to 1. 19).